Pulmonary hypertension: its assessment and treatment.
作者信息
Brij S, Peacock A J
机构信息
Scottish Pulmonary Vascular Unit, Western Infirmary, Glasgow, UK.
出版信息
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S28-32. doi: 10.1136/thx.54.2008.s28.
Abstract
摘要
相似文献
1
Pulmonary hypertension: its assessment and treatment.
Thorax. 1999 Aug;54 Suppl 2(Suppl 2):S28-32. doi: 10.1136/thx.54.2008.s28.
2
Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Transplant Proc. 2001 Feb-Mar;33(1-2):1332. doi: 10.1016/s0041-1345(00)02807-4.
3
High levels of nitric oxide in individuals with pulmonary hypertension receiving epoprostenol therapy.
Lung. 2001;179(4):233-43. doi: 10.1007/s004080000064.
4
A new era in the treatment of primary pulmonary hypertension.原发性肺动脉高压治疗的新时代。
Heart. 2001 Mar;85(3):251-2. doi: 10.1136/heart.85.3.251.
5
Treatment of pulmonary arterial hypertension.肺动脉高压的治疗。
N Engl J Med. 2004 Sep 30;351(14):1425-36. doi: 10.1056/NEJMra040291.
6
Vasodilators in the treatment of primary pulmonary hypertension.
Eur Respir J. 1998 Aug;12(2):263-4. doi: 10.1183/09031936.98.12020263.
7
Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.依前列醇治疗可逆转原发性肺动脉高压患者的一氧化氮无反应性。
Heart. 2000 Apr;83(4):406-9. doi: 10.1136/heart.83.4.406.
8
[Pulmonary hypertension].[肺动脉高压]
Internist (Berl). 2002 Dec;43(12):1498, 1501-9. doi: 10.1007/s00108-002-0761-z.
9
Advances in prostacyclin therapy for pulmonary arterial hypertension.
Crit Care Nurse. 2004 Apr;24(2):42-8, 50-4.
10
[Treatment of pulmonary artery hypertension].
Pneumologie. 2000 Jun;54(6):222-4. doi: 10.1055/s-2000-3823.
引用本文的文献
1
Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.雾化维拉帕米治疗慢性阻塞性肺疾病相关性肺动脉高压患者的临床评估。
Clin Respir J. 2022 Dec;16(12):802-811. doi: 10.1111/crj.13551. Epub 2022 Nov 6.
2
Beraprost sodium for chronic diabetic foot ulcer: a randomized controlled trial in thammasat university hospital.贝前列素钠治疗慢性糖尿病足溃疡：泰国法政大学医院的一项随机对照试验
Ann Vasc Dis. 2014;7(1):40-5. doi: 10.3400/avd.oa.13-00092. Epub 2014 Feb 28.
3
Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.贝拉前列腺素：其药理学及治疗外周动脉疾病和肺动脉高压疗效的综述
Drugs. 2002;62(1):107-33. doi: 10.2165/00003495-200262010-00005.
本文引用的文献
1
A survey of diagnostic practices and the use of epoprostenol in patients with primary pulmonary hypertension.
Chest. 1998 Nov;114(5):1269-75. doi: 10.1378/chest.114.5.1269.
2
Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.吸入一氧化氮作为一种筛查剂，用于在原发性肺动脉高压中安全识别对口服钙通道阻滞剂有反应者。
Eur Respir J. 1998 Aug;12(2):265-70. doi: 10.1183/09031936.98.12020265.
3
Exhaled nitric oxide and pulmonary response to iloprost in systemic sclerosis with pulmonary hypertension.
Lancet. 1998 May 16;351(9114):1491-2. doi: 10.1016/S0140-6736(05)78874-7.
4
An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension.雾化吸入前列环素治疗原发性和继发性肺动脉高压患者的评估
Eur Heart J. 1997 Sep;18(9):1499-504. doi: 10.1093/oxfordjournals.eurheartj.a015478.
5
Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension.原发性肺动脉高压患者长期使用依前列醇（前列环素）治疗可降低肺血管阻力。
N Engl J Med. 1998 Jan 29;338(5):273-7. doi: 10.1056/NEJM199801293380501.
6
7
Effects of inhaled versus intravenous vasodilators in experimental pulmonary hypertension.吸入性与静脉注射血管扩张剂对实验性肺动脉高压的影响。
Eur Respir J. 1997 May;10(5):1084-92. doi: 10.1183/09031936.97.10051084.
8
Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension.人类免疫缺陷病毒感染患者的肺动脉高压。与原发性肺动脉高压的比较。
Circulation. 1994 Jun;89(6):2722-7. doi: 10.1161/01.cir.89.6.2722.
9
Inhaled nitric oxide as a screening vasodilator agent in primary pulmonary hypertension. A dose-response study and comparison with prostacyclin.
Am J Respir Crit Care Med. 1995 Feb;151(2 Pt 1):384-9. doi: 10.1164/ajrccm.151.2.7842196.
10
Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension.
Chest. 1995 Jan;107(1):54-7. doi: 10.1378/chest.107.1.54.
Zotero 插件